Shanghai Rongtai Health Technology Corp (603579.SS) Stock Price
Shanghai Rongtai Health Technology Corp Price
Revenue has compounded at 11.8% per year over the past 14 years to 1.57 B CNY. Earnings per share have grown at 16.1% per year over the last 14 years. Shanghai Rongtai Health Technology Corp's net margin stands at 9.6%, broadly stable from 9.0% several years earlier. Shanghai Rongtai Health Technology Corp currently offers a dividend yield of about 2.10%. The payout ratio is around 42% of earnings. The dividend has grown at 5.3% per year over the past 8 years. Analysts set a median price target of 32.10 CNY, implying 92.2% above the current price. Of 6 analysts, 4 rate the stock a buy — an overall Buy consensus.
Shanghai Rongtai Health Technology Corp stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Shanghai Rongtai Health Technology Corp business model & stock analysis
Frequently asked questions about Shanghai Rongtai Health Technology Corp
Analysts currently set an average price target of 32.10 CNY for the Shanghai Rongtai Health Technology Corp stock (median: 32.10 CNY), implying +92.2 % versus the latest price. The consensus is based on 6 analyst ratings.
Shanghai Rongtai Health Technology Corp Analyst Price Targets 2026
6 analysts currently rate the Shanghai Rongtai Health Technology Corp stock: 4 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Shanghai Rongtai Health Technology Corp to generate revenue of 1.87 B CNY and earnings per share of 0.83 CNY.
Shanghai Rongtai Health Technology Corp Analyst Price Targets 2026
Converted at the current exchange rate, the Shanghai Rongtai Health Technology Corp share trades at 2.25 EUR (16.70 CNY).
The Shanghai Rongtai Health Technology Corp share (603579.SS) is listed on 1 stock exchanges, including: Shanghai (603579.SS).
The expected revenue of Shanghai Rongtai Health Technology Corp is 1.87 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Shanghai Rongtai Health Technology Corp is 148.41 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Shanghai Rongtai Health Technology Corp is currently 20.19. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Shanghai Rongtai Health Technology Corp stock.
The price-to-sales ratio (P/S) of Shanghai Rongtai Health Technology Corp is currently 1.60. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Shanghai Rongtai Health Technology Corp stock.
The Eulerpool Quality Score for Shanghai Rongtai Health Technology Corp is 3/10.
The ISIN of Shanghai Rongtai Health Technology Corp is CNE100002R81. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Shanghai Rongtai Health Technology Corp is 603579.SS. The ticker symbol is used to trade Shanghai Rongtai Health Technology Corp shares on the stock exchange.
Shanghai Rongtai Health Technology Corp stock
Shanghai Rongtai Health Technology Corp Peer Group
Shanghai Rongtai Health Technology Corp Ticker
Shanghai Rongtai Health Technology Corp FIGI
All fundamentals and in-depth analysis of Shanghai Rongtai Health Technology Corp
Our stock analysis for Shanghai Rongtai Health Technology Corp stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shanghai Rongtai Health Technology Corp. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.